This study identifies two distinct metabolic mechanisms underlying defective secondary platelet aggregation, differentiating between storage pool deficiency and aspirin-like release defects.
No takes yet. Share an insight, caveat, or question.
Differentiates storage pool from release defects in rare aggregation disorders; leaves open diagnostic utility in larger cohorts.
Pareti et al. (1974) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: